The expression levels of PKM2 and LDHA were significantly decreased together with β-catenin and proliferating cell nuclear antigen (PCNA) by KYA1797K treatment in the tumour area of the small intestine from Apcmin/+ mice compared with those of vehicle-treated mice (Fig. 4a, b). This evidence concerns the gene PCNA and neoplasm.